To include your compound in the COVID-19 Resource Center, submit it here.

Looking for a rising tide

Looking for a rising tide

For those waiting for some event to re-establish the biotechnology model and create a rising tide of investor interest in the sector, last week's boffo Wall Street response to Biogen's multiple sclerosis announcement must have raised hopes.

As the graphic above shows, however, BGEN's big splash didn't immediately raise the water level in the bathtub for the rest of the sector.

In fact, investor skepticism continues to ring loudly across the sector,

Read the full 758 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers